公开(公告)号：US20110066054A1

公开(公告)日：2011-03-17

申请号：US12882126

申请日：2010-09-14

Applicant: Refet Firat Yazicioglu ,  Sunyoung Kim

Inventor： Refet Firat Yazicioglu ,  Sunyoung Kim

IPC: A61B5/0402 ,  A61B5/053

CPC classification number: A61B5/0531 ,  A61B5/04 ,  A61B5/0402 ,  A61B5/0428 ,  A61B5/0476 ,  A61B5/0488 ,  A61B5/7225 ,  G01R19/2509

Abstract: A method and device is disclosed for continuously and simultaneously measuring an impedance signal and a biopotential signal on a biological subject's skin. In one aspect, the method includes attaching input and output electrodes to the biological subject's skin and applying a predetermined alternating current having a first frequency to the output electrodes for creating an alternating voltage signal over the input electrodes. The first frequency is above a predetermined minimum frequency. The method also includes measuring an input signal from the input electrodes which includes a biopotential signal and the alternating voltage signal. The method also includes extracting from the input signal the biopotential signal and the alternating voltage signal, and determining the impedance signal from the alternating voltage signal. The alternating voltage signal is extracted by amplifying and demodulating the input signal using a control signal having a frequency equal to the first frequency.

Abstract translation: 公开了用于连续并同时测量生物学对象皮肤上的阻抗信号和生物电位信号的方法和装置。 在一个方面，该方法包括将输入和输出电极附接到生物学对象的皮肤，并将具有第一频率的预定交流电施加到输出电极，以在输入电极上产生交流电压信号。 第一频率高于预定的最小频率。 该方法还包括测量来自输入电极的输入信号，其包括生物电位信号和交流电压信号。 该方法还包括从输入信号提取生物电位信号和交流电压信号，以及从交流电压信号确定阻抗信号。 通过使用具有等于第一频率的频率的控制信号来放大和解调输入信号来提取交流电压信号。

公开(公告)号：US20110056551A1

公开(公告)日：2011-03-10

申请号：US12878555

申请日：2010-09-09

Applicant: Sunyoung KIM ,  Youngho Choe

Inventor： Sunyoung KIM ,  Youngho Choe

IPC: H01L31/0236 ,  H01L31/18

CPC classification number: H01L31/022458 ,  H01L31/02168 ,  H01L31/022425 ,  H01L31/022441 ,  H01L31/0236 ,  H01L31/02363 ,  H01L31/0516 ,  H01L31/0682 ,  Y02E10/50 ,  Y02E10/547

Abstract: A solar cell and a method for manufacturing the same are discussed. The solar cell includes a semiconductor substrate, a first doped region of a first conductive type, a second doped region of a second conductive type opposite the first conductive type, a back passivation layer having contact holes exposing a portion of each of the first and second doped regions, a first electrode formed on the first doped region exposed through the contact holes, a second electrode formed on the second doped region exposed through the contact holes, an alignment mark formed at one surface of the semiconductor substrate, and a textured surface that is formed at a light receiving surface of the semiconductor substrate opposite the one surface of the semiconductor substrate in which the first and second doped regions are formed.

Abstract translation: 讨论太阳能电池及其制造方法。 太阳能电池包括半导体衬底，第一导电类型的第一掺杂区域，与第一导电类型相反的第二导电类型的第二掺杂区域，具有暴露第一和第二导电类型中的每一个的接触孔的背面钝化层 掺杂区域，形成在通过接触孔暴露的第一掺杂区域上的第一电极，形成在通过接触孔暴露的第二掺杂区域上的第二电极，形成在半导体衬底的一个表面处的对准标记和纹理表面， 形成在与形成有第一和第二掺杂区域的半导体衬底的一个表面相对的半导体衬底的光接收表面上。

公开(公告)号：US20100206369A1

公开(公告)日：2010-08-19

申请号：US12705532

申请日：2010-02-12

Applicant: Sunyoung KIM ,  Choul Kim ,  Youngho Choe ,  Sungeun Lee

Inventor： Sunyoung KIM ,  Choul Kim ,  Youngho Choe ,  Sungeun Lee

IPC: H01L31/0352 ,  H01L31/18

CPC classification number: H01L31/0682 ,  H01L31/02167 ,  H01L31/02168 ,  H01L31/022441 ,  H01L31/035281 ,  H01L31/03529 ,  H01L31/1804 ,  Y02E10/52 ,  Y02E10/547 ,  Y02P70/521

Abstract: A solar cell and a method for manufacturing the same are disclosed. The solar cell includes a semiconductor layer containing first impurities, a first portion positioned on a first part of one surface of the semiconductor layer, the first portion being more heavily doped with second impurities different from the first impurities than the semiconductor layer, a second portion positioned on a second part of the one surface of the semiconductor layer, the second portion being more heavily doped with the first impurities than the semiconductor layer, and a third portion positioned between the first portion and the second portion, the third portion having an impurity concentration lower than an impurity concentration of the first portion and an impurity concentration of the second portion.

Abstract translation: 公开了一种太阳能电池及其制造方法。 太阳能电池包括含有第一杂质的半导体层，位于半导体层的一个表面的第一部分上的第一部分，第一部分被重掺杂有与半导体层不同于第一杂质的第二杂质，第二部分 位于半导体层的一个表面的第二部分上，第二部分比半导体层更加重掺杂第一杂质，第三部分位于第一部分与第二部分之间，第三部分具有杂质 浓度低于第一部分的杂质浓度和第二部分的杂质浓度。

公开(公告)号：US20100104899A1

公开(公告)日：2010-04-29

申请号：US12429233

申请日：2009-04-24

Applicant: Joongmyeon Bae ,  Sangho Yoon ,  Sunyoung Kim

Inventor： Joongmyeon Bae ,  Sangho Yoon ,  Sunyoung Kim

IPC: H01M8/06

CPC classification number: H01M8/0618 ,  B01J8/0465 ,  B01J2219/1923 ,  B01J2219/1943 ,  C01B3/26 ,  C01B3/38 ,  C01B3/382 ,  C01B3/58 ,  C01B2203/0244 ,  C01B2203/0277 ,  C01B2203/0435 ,  C01B2203/0485 ,  C01B2203/066 ,  C01B2203/1005 ,  C01B2203/1041 ,  C01B2203/1047 ,  C01B2203/1058 ,  C01B2203/1064 ,  C01B2203/107 ,  C01B2203/1082 ,  C01B2203/142 ,  C01B2203/143 ,  C01B2203/146 ,  H01M8/0631 ,  H01M8/0675 ,  H01M2008/1293

Abstract: A unified fuel processing reactor for a solid oxide fuel cell can reform hydrocarbon-based fuel into hydrogen-rich gas, remove a sulfur component, and convert non-converted fuel and a low carbon (C2˜C5) hydrocarbon compound into hydrogen and methane in a single reactor. The reactor comprises a primary-reformer which reforms a hydrocarbon-base fuel and generates hydrogen-rich reformed gas, a desulfurizer which removes a sulfur component from the reformed gas, and a post-reformer which selectively decomposes a low carbon (C2˜C5) hydrocarbon in the desulfurized reformed gas into hydrogen and methane. The primary-reformer, desulfurizer and post-reformer are in the unified reactor and isolated, except for a fluid passage, from each other by internal partition walls. The primary-reformer is disposed at a center portion of the reactor. The post-reformer and the desulfurizer are concentrically disposed outside of the primary-reformer.

Abstract translation: 用于固体氧化物燃料电池的统一燃料处理反应器可以将烃类燃料转化为富氢气体，除去硫成分，并将未转化燃料和低碳（C 2 -C 5）烃化合物转化成氢气和甲烷 一个反应堆。 该反应器包括改性烃基燃料并产生富氢重整气体的一次重整器，从重整气体中除去硫成分的脱硫器和选择性分解低碳（C2〜C5）的后重整器， 将脱硫改质气体中的烃转化为氢气和甲烷。 初级重整器，脱硫器和后改性器在统一的反应器中，除了流体通道之外，通过内部分隔壁彼此隔离。 初级重整器设置在反应器的中心部分。 后改性剂和脱硫剂同心地放置在初级重整器之外。

公开(公告)号：US20070140120A1

公开(公告)日：2007-06-21

申请号：US11637724

申请日：2006-12-13

Applicant: Seong-Jun Song ,  Namjun Cho ,  Sunyoung Kim ,  Hoi-Jun Yoo

Inventor： Seong-Jun Song ,  Namjun Cho ,  Sunyoung Kim ,  Hoi-Jun Yoo

IPC: H04L12/26 ,  H04J3/06

CPC classification number: H04B13/005 ,  H04L7/00

Abstract: In circumstance of a wearable computing system, in order to effectively transfer data between electronic devices using electric property of human body, minimization, low power, and high-speed are required. Human body data communication apparatus and module using broadband signaling technology is provided to perform high-speed peer-to-peer data communication with a signal electrode and low power. The apparatus and module have a direct coupling interface with a single electrode without an antenna and a sensor, and a transmitter transmitting digital signal without modulation, and a receiver recovering a clock and data by detecting a broadband pulse signal.

Abstract translation: 在可穿戴式计算系统的情况下，为了在使用人体的电气性能的电子设备之间有效地传输数据，需要最小化，低功率和高速度。 提供使用宽带信令技术的人体数据通信装置和模块，以与信号电极进行高速对等数据通信和低功率。 该装置和模块具有与没有天线和传感器的单个电极的直接耦合接口，以及无调制地发射数字信号的发射器，以及通过检测宽带脉冲信号来恢复时钟和数据的接收器。

公开(公告)号：US20070122508A1

公开(公告)日：2007-05-31

申请号：US11522511

申请日：2006-09-18

Applicant: Sunyoung Kim ,  Eun Park ,  Bongcheol Kim ,  Mirim Jin ,  Hwa Lee

Inventor： Sunyoung Kim ,  Eun Park ,  Bongcheol Kim ,  Mirim Jin ,  Hwa Lee

IPC: A61K36/185

CPC classification number: A23L33/105 ,  A23V2002/00 ,  A61K36/185 ,  A23V2250/70 ,  A23V2250/21 ,  A23V2250/72 ,  A23V2250/7056 ,  A23V2250/705 ,  A23V2250/156 ,  A23V2250/032 ,  A23V2250/28 ,  A23V2250/0644

Abstract: The present invention provides a pharmaceutical composition comprising the extract of hardy kiwifruit as an active ingredient in an effective amount to treat and prevent allergic disease and non-allergic inflammatory disease by reducing inflammation action, by inhibiting histamine release from mast cell, and by increasing the level of Th1 cytokines, IgG2a in serum and reducing the level of Th2 cytokines and IgE in serum. The present invention also provides a use of above extract for the preparation of pharmaceutical composition. The present invention also provides a health food or food additives, a cosmetic composition, a feed or feed additives comprising above extract for prevention or alleviation of allergic disease and non-allergic inflammatory disease by reducing inflammation action, by inhibiting histamine release from mast cell, and by increasing the level of Th1 cytokines, IgG2a in serum, and reducing the level of Th2 cytokines and IgE in serum.

Abstract translation: 本发明提供一种药物组合物，其含有作为有效成分的强力猕猴桃提取物，通过抑制组织胺从肥大细胞释放而通过减少炎症作用，以及通过增加免疫反应来治疗和预防过敏性疾病和非变应性炎性疾病 血清中Th1细胞因子水平，IgG2a水平，降低血清中Th2细胞因子和IgE水平。 本发明还提供了上述提取物用于制备药物组合物的用途。 本发明还提供一种保健食品或食品添加剂，化妆品组合物，饲料或饲料添加剂，其包含通过抑制组织胺从肥大细胞释放而防止或减轻过敏性疾病和非变应性炎性疾病的上述提取物， 并通过增加血清中Th1细胞因子，IgG2a的水平，降低血清中Th2细胞因子和IgE的水平。

公开(公告)号：US20050277603A1

公开(公告)日：2005-12-15

申请号：US10220824

申请日：2002-01-03

Applicant: Jong-Mook Kim ,  Seong-Hyun Ho ,  Eun-Jin Park ,  Sunyoung Kim

Inventor： Jong-Mook Kim ,  Seong-Hyun Ho ,  Eun-Jin Park ,  Sunyoung Kim

IPC: C12N15/09 ,  A61K35/12 ,  A61K35/76 ,  A61K38/00 ,  A61K38/19 ,  A61K38/22 ,  A61K38/39 ,  A61K38/48 ,  A61K48/00 ,  A61P29/00 ,  A61P43/00 ,  C07K14/47 ,  C12N15/867

CPC classification number: A61K48/005 ,  A01K2267/0325 ,  A61K35/33 ,  A61K38/195 ,  A61K38/39 ,  A61K38/484 ,  A61K48/00 ,  C07K2319/02 ,  C12N15/86 ,  C12N2740/13043

Abstract: The present invention relates to the compositions for a gene therapy of rheumatoid arthritis including a gene encoding an anti-angiogenic protein or parts thereof. More specifically, the present invention provides a gene therapy of rheumatoid arthritis by preparing a recombinant vector that expresses a gene encoding an anti-angiogenic protein such as angiostatin or parts thereof, and transplanting the recombinant vector or a cell that is transfected or transduced with the recombinant vector into the affected area of a patient, and also provides the compositions for the gene therapy. The compositions for the gene therapy according to the present invention can be used effectively for the treatment of rheumatoid arthritis, for which effective treating methods have not been developed until now, by providing the anti-angiogenic proteins into the knee of a patient continuously to prevent the synovial tissue hyperplasia and the resulting inflammation.

Abstract translation: 本发明涉及用于类风湿性关节炎基因治疗的组合物，包括编码抗血管生成蛋白质的基因或其部分。 更具体地，本发明通过制备表达编码抗血管生成蛋白质的基因的重组载体，例如血管抑素或其部分，提供类风湿性关节炎的基因治疗，并移植重组载体或转染或转导的细胞 重组载体进入患者的受影响区域，并且还提供用于基因治疗的组合物。 根据本发明的基因治疗组合物可以有效地用于治疗类风湿性关节炎，通过将抗血管生成蛋白质连续地提供给患者的膝盖以防止其发生，迄今尚未开发出有效的治疗方法 滑膜组织增生和由此引起的炎症。

公开(公告)号：US20160298168A1

公开(公告)日：2016-10-13

申请号：US15094315

申请日：2016-04-08

Applicant: Sunyoung Kim

Inventor： Sunyoung Kim

IPC: C12Q1/34 ,  A61K31/198 ,  A61K31/506 ,  A61K31/505

CPC classification number: C12Q1/34 ,  A61B5/0059 ,  A61K31/198 ,  A61K31/505 ,  A61K31/506 ,  C12Q1/6886 ,  C12Q2600/106 ,  C12Q2600/156 ,  G01N33/574 ,  G01N2333/914 ,  G01N2500/04 ,  G01N2800/52

Abstract: A rapid, infrared spectroscopic method has been developed to assess the efficacy of targeted chemotherapeutics against the structure of the polypeptide target, based on the effect of natural polymorphic sequence variation on the conformation of the protein. This method has an advantage over the current genomics-based screening, as the new method provides a direct readout of the structural, and hence functional, outcome of polymorphisms to the protein region targeted by drugs. It allows rapid measurement of a protein's susceptibility to therapeutic targeted agents, prior to using the drug as treatment in the patient. This method can be used to identify biomarkers for a response for a protein to a drug which can be readily tested, interpreted, and used in a clinical setting.

Abstract translation: 基于天然多态性序列变异对蛋白质构象的影响，开发了一种快速的红外光谱方法，以评估靶向化学治疗剂对多肽靶结构的功效。 该方法相对于目前基于基因组学的筛选具有优势，因为新方法提供了针对药物的蛋白质区域的多态性的结构，从而功能性的结果的直接读出。 在使用药物作为患者的治疗之前，它可以快速测量蛋白质对治疗性靶向药物的敏感性。 该方法可用于鉴定蛋白质对药物的响应的生物标志物，其可以容易地在临床环境中测试，解释和使用。

公开(公告)号：US08883344B2

公开(公告)日：2014-11-11

申请号：US13251478

申请日：2011-10-03

Applicant: Sinyoung Park ,  Yongbeom Lee ,  Sunyoung Kim ,  Bora Lee

Inventor： Sinyoung Park ,  Yongbeom Lee ,  Sunyoung Kim ,  Bora Lee

IPC: H01M6/04 ,  H01M6/16 ,  H01M10/42 ,  H01M10/0567

CPC classification number: H01M10/0567 ,  H01M6/168 ,  H01M10/4235 ,  H01M2300/0034 ,  H01M2300/004 ,  Y02E60/12

Abstract: An electrolyte for a lithium secondary battery having flame retardancy, low negative electrode interfacial resistance, and excellent high temperature properties and life characteristics, and a lithium secondary battery including the same. An electrolyte for a lithium secondary battery of the present invention may include a non-aqueous organic solvent, a lithium salt, fluorinated ether or phosphazene, and a resistance-improving additive represented as the following chemical formula (1): FSO2—R1—SO2F  [Chemical Formula 1] wherein R1 is a C1-C12 hydrocarbon unsubstituted or substituted with at least one fluorine.

Abstract translation: 具有阻燃性，低负极界面电阻和优异的高温性能和寿命特性的锂二次电池用电解液以及包含该锂二次电池的锂二次电池。 本发明的锂二次电池用电解质可以包括非水有机溶剂，锂盐，氟化醚或磷腈，以及以下化学式（1）表示的电阻改进添加剂：FSO 2 -R 1 -SO 2 F [化学式1]其中R1是未被取代或被至少一个氟取代的C1-C12烃。

公开(公告)号：US20120164519A1

公开(公告)日：2012-06-28

申请号：US13240881

申请日：2011-09-22

Applicant: Bora LEE ,  Yongbeom Lee ,  Sinyoung Park ,  Sunyoung Kim

Inventor： Bora LEE ,  Yongbeom Lee ,  Sinyoung Park ,  Sunyoung Kim

IPC: H01M10/056 ,  H01M2/02

CPC classification number: H01M10/0567 ,  H01M6/16 ,  H01M6/164 ,  H01M6/168 ,  H01M10/052 ,  H01M10/0569 ,  H01M10/4235 ,  H01M2300/0025 ,  H01M2300/0034 ,  H01M2300/0037 ,  H01M2300/004 ,  Y02E60/122

Abstract: The present disclosure relates to an electrolyte for a lithium secondary battery capable of improving safety and reliability of the lithium secondary battery and a lithium secondary battery comprising the electrolyte. The electrolyte for a lithium secondary battery of the present embodiments comprises a non-aqueous organic solvent, a lithium salt, flame retarding materials of fluoroalkyl ether and phosphazene, and a solvent comprising at least one ester.

Abstract translation: 本发明涉及能提高锂二次电池的安全性和可靠性的锂二次电池用电解质以及包含电解质的锂二次电池。 本实施方案的锂二次电池用电解质包括非水有机溶剂，锂盐，氟代烷基醚和磷腈的阻燃材料，以及含有至少一种酯的溶剂。